Quick Answer
Mineralys Therapeutics, Inc. reported Common Stock Shares Outstanding of 81.54 million shares for the year ending 2025.
- Mineralys Therapeutics, Inc. showed an increase of +63.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Mineralys Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Mineralys Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 1,170.2%.
- Historical annual values: Fiscal year 2025: 81.54 million shares | Fiscal year 2024: 49.82 million shares | Fiscal year 2023: 41.13 million shares | Fiscal year 2022: 6.42 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: